What is it about?
The study showed that Gene-Eden-VIR/Novirin safely and effectively decreased the duration of genital herpes outbreaks. Acyclovir, valacyclovir, and famciclovir are the three leading drugs for genital herpes. These drugs have side effects. Therefore, doctors usually recommend suppressive, or long term use of these drugs in only severe cases. In contrast, long term use of Gene-Eden-VIR/Novirin had no side effects. As a result, the study recommends “suppressive (or long term) treatment with Gene-Eden-VIR/Novirin as a natural alternative to both suppressive (long term) and episodic (short term) treatments with current drugs, in both severe and mild genital herpes cases.”
Featured Image
Why is it important?
The paper reports the results of a clinical study that tested the effect of long term treatment with Gene-Eden-VIR/Novirin on genital herpes outbreaks, in both severe and mild cases. The study showed that such treatment is safe and effective, and therefore, should be recommended by healthcare professionals.
Perspectives
A previous study compared Gene-Eden-VIR/Novirin with acyclovir, valacyclovir, and famciclovir, the three drugs that are widely used by doctors as the first-line treatment in genital herpes. Surprisingly, the study showed that the natural antiviral Gene-Eden-VIR/Novirin is more effective and safer than these drugs. This paper was published in the highly respected medical journal Drug Design, Development and Therapy. This paper is indexed on Pubmed.com, at: http://www.ncbi.nlm.nih.gov/pubmed/27621592. A video, which presents Dr. Hanan Polansky and Dr. Edan Itzkovitz discussing their study, is available at https://youtu.be/kJzAYDEEJt0. According to Dr. Hanan Polansky, the lead author of both studies, “To the best of our knowledge, these two studies are a major turning point for dietary supplements. They show, for the first time, that a dietary supplement can be more effective than the leading drugs in an important drug category.”
Dr. Hanan Polansky
The Center for the Biology of Chronic Disease (CBCD)
Read the Original
This page is a summary of: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases, Clinical and Translational Medicine, October 2016, Springer Science + Business Media,
DOI: 10.1186/s40169-016-0121-6.
You can read the full text:
Contributors
The following have contributed to this page
